Talarozole
N/A
Report date: 2024/11/08 16:49:21
NME
Base Information
Drug NameTalarozole
Drug Alias Name +[8]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[6]
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesStiefel LaboratoriesGlaxosmithkline Plc
Active IndicationsN/A
Inactive Indications